Medial ganglionic eminence (MGE)-derived GABAergic cortical interneurons (cINs) consist of multiple subtypes that are involved in many cortical functions. They also have a remarkable capacity to migrate, survive and integrate into cortical circuitry after transplantation into postnatal cortex. These features have engendered considerable interest in generating distinct subgroups of interneurons from pluripotent stem cells (PSCs) for the study of interneuron fate and function, and for the development of cell-based therapies. Although advances have been made, the capacity to generate highly enriched pools of subgroup fatecommitted interneuron progenitors from PSCs has remained elusive. Previous studies have suggested that the two main MGE-derived interneuron subgroups -those expressing somatostatin (SST) and those expressing parvalbumin (PV) -are specified in the MGE from Nkx2.1-expressing progenitors at higher or lower levels of sonic hedgehog (Shh) signaling, respectively. To further explore the role of Shh and other factors in cIN fate determination, we generated a reporter line such that Nkx2.1-expressing progenitors express mCherry and postmitotic Lhx6-expressing MGE-derived interneurons express GFP. Manipulations of Shh exposure and time in culture influenced the subgroup fates of ESC-derived interneurons. Exposure to higher Shh levels, and collecting GFP-expressing precursors at 12 days in culture, resulted in the strongest enrichment for SST interneurons over those expressing PV, whereas the strongest enrichment for PV interneurons was produced by lower Shh and by collecting mCherry-expressing cells after 17 days in culture. These findings confirm that fate determination of cIN subgroups is crucially influenced by Shh signaling, and provide a system for the further study of interneuron fate and function.
INTRODUCTION
In the mammalian neocortex, GABAergic cortical interneurons (cINs) facilitate cognition by providing inhibitory inputs to cortical circuitry (Lehmann et al., 2012; Fino et al., 2013) . Consequently, interneuron dysfunction is associated with a variety of neurological diseases, including seizure disorders, schizophrenia and autism (Belforte et al., 2010; Chao et al., 2010; Inan et al., 2013) . Interneurons are classified into functionally distinct subgroups based on neurochemical markers, connectivity profiles and electrophysiological properties (DeFelipe et al., 2013) , with specific subtypes being implicated in different disease etiologies (Binaschi et al., 2003; Levitt et al., 2004; Inan et al., 2013; Jiang et al., 2013; Smith-Hicks, 2013) . Genetic fate mapping and transplantation studies have revealed that cINs arise from the ganglionic eminences (GEs) of the subcortical telencephalon. Nearly all of these can be divided into non-overlapping subgroups that express one of three markers: parvalbumin (PV; Pvalb -Mouse Genome Informatics) or somatostatin (SST), which originate in the medial ganglionic eminence (MGE), and 5HT3aR, which originates in the caudal ganglionic eminence (Lee et al., 2010; Rudy et al., 2011) . Together, the PV and SST-expressing subgroups, which have distinct electrophysiological and axon-targeting properties (Kawaguchi and Kubota, 1997; , constitute ∼60% of all cINs in the mouse frontal cortex (Tamamaki et al., 2003; Xu et al., 2010b) . These MGE-derived interneurons require the expression of the transcription factor Nkx2.1 during the progenitor stage (Sussel et al., 1999; Xu et al., 2004; Butt et al., 2008) , then downregulate this gene to facilitate migration into the cortex (Nóbrega-Pereira et al., 2008) . Upstream of Nkx2.1, sonic hedgehog (Shh) is required for the induction and maintenance of Nkx2.1 (Xu et al., 2005) , and higher levels of Shh bias MGE progenitors to SST-expressing interneuron fates, whereas lower levels bias for the PV-expressing subgroup [ (Xu et al., 2010a) ; but see also (Flandin et al., 2011) ]. Downstream of Nkx2.1, its direct target Lhx6 is maintained in MGE-derived interneurons from cell cycle exit through postnatal development and is necessary for their normal development (Lavdas et al., 1999; Sussel et al., 1999; Liodis et al., 2007; Du et al., 2008; Zhao et al., 2008; Flandin et al., 2011; Vogt et al., 2014) .
Due to their remarkable ability to migrate, integrate and influence local activity after transplantation into the postnatal brain, there has been considerable interest in deriving cINs from pluripotent stem cells (PSCs) to be used in cell-based therapies for interneuron-related diseases (Goulburn et al., 2012; Southwell et al., 2014; Tyson and Anderson, 2014) . Protocols have been established to derive these neurons from both mouse and human PSCs (Watanabe et al., 2005; Goulburn et al., 2011; Maroof et al., 2010 Maroof et al., , 2013 Danjo et al., 2011; Au et al., 2013; Chen et al., 2013; Nicholas et al., 2013; Petros et al., 2013) . However, despite the relevance to cell-based therapies, progress in generating enriched populations of interneuron subgroups has been slow. Recently, success in increasing the generation of PV relative to SST-expressing interneurons was achieved by expression of Lmo3 after expression of Nkx2.1 and Dlx2 (Au et al., 2013) . Here, we test the hypothesis that, if PSC differentiation parallels key aspects of native interneuron development, manipulation of Shh signaling, together with the timing of collection of interneuron precursors, should enrich for SST or PV interneuron subgroups without the need for transgenic expression of fate-determining factors. Indeed, a higher level of Shh exposure and earlier harvest of interneuron precursors allows for a roughly 4:1 bias for SST-expressing interneurons, whereas low Shh signaling conditions and later harvest results in a similar bias for the PV subgroup. These findings confirm that fate determination of cIN subgroups is crucially influenced by Shh signaling. In addition, we provide a system for the further study of interneuron fate and function, as well as for the development of interneuron subgroup-selective transplantation therapies for treating a variety of neurological disorders, in which dysfunctional GABAergic signaling is a shared pathological mechanism.
RESULTS

Efficient telencephalic patterning in mESCs
Previous studies have generated cIN-like cells from mESCs (Watanabe et al., 2005; Maroof et al., 2010; Danjo et al., 2011; Maisano et al., 2012; Au et al., 2013; Chen et al., 2013; Petros et al., 2013) . However, a protocol to efficiently enrich for pallidal telencephalic progenitors, as evidenced by a majority of cells expressing transcription factors Foxg1 and Nkx2.1, has been elusive. Consequently, we sought to improve the telencephalic induction in our differentiation paradigm. An organized cross-regulation of Shh and Wnt signaling is required for normal forebrain development, whereby Wnts are strongly expressed in the dorsal and caudal domains of the developing central nervous system (CNS) (Gaspard and Vanderhaeghen, 2011; Houart et al., 2002; Ohkubo et al., 2002; Shimogori et al., 2004; Hébert and Fishell, 2008) (schematized in Fig. 1A ,Aa). In the mouse embryo, Dkk1 is an endogenous Wnt inhibitor (Glinka et al., 1998) , in which a signaling gradient of Wnt/β-catenin and Dkk1 mediates anterior-posterior (AP) axis polarization (Houart et al., 2002; Ohkubo et al., 2002; Shimogori et al., 2004; Niehrs, 2006) (schematized in Fig. 1A,Aa) . Therefore, through early Wnt signaling inhibition, we expected to bias cells towards a rostro-ventral pallidal fate. The use of Wnt-inhibitory molecules such as Dkk1 has been previously proposed for the derivation of telencephalic and optic progenitors during mouse and human ESC differentiation (Watanabe et al., 2005; Lamba et al., 2006) . Using a modification of our previously published protocol for the generation of cINs (Fig. 1B) (Maroof et al., 2010) , we found that, in lieu of Dkk1, adding the tankyrase inhibitor XAV939 (Huang et al., 2009 ) from differentiation day (DD) 0-5 greatly enhanced the generation of pallidal telencephalic progenitors, as evidenced by Foxg1 and Nkx2.1 expression (Fig. 1C, quantified in Fig. 1D,Da) . Foxg1 + cells appeared as early as DD6 ( Fig. 1Ea,Fa; 13.7±1.5% −XAV versus 32.0±6.5% +XAV, P=0.03). By DD9, Foxg1 expression increased in rosette-like clusters that began to form (26.8±5.9% −XAV versus 75.9±9.0% +XAV, P=0.002; Fig. 1Eb ,Fb). Foxg1 expression peaked at DD12 in our +XAV condition, when neural rosettes comprise the majority of the culture dish (Fig. 1Ec ,Fc, quantified in Fig. 1D ; 14.8±3.4% −XAV versus 87.3±9.6% +XAV P=0.002). By DD12, XAV-treated differentiations resulted in a 20-fold increase in Nkx2.1 labeling ( Fig. 1G ; 2.1±1.2% −XAV versus 46.7±9.1% + XAV). XAV treatment also greatly increased the production of Tuj1 (Tubb3 -Mouse Genome Informatics)-expressing neurons (supplementary material Fig. S2) .
A dual-reporter mESC line for the isolation of interneuronfated cells at the progenitor and post-mitotic stages Previously, we demonstrated that a mESC line modified to express GFP under control of the Lhx6-containing bacterial artificial chromosome (BAC) could be used to isolate putative interneuron precursors, and to identify the two main subclasses of MGE-derived interneurons post transplantation. These included the PV-and SSTexpressing subgroups, which were further characterized with electrophysiology, including the presence of 'fast-spiking' action potential trains in the PV-expressing interneurons and non-fastspiking trains in the SST interneurons (Maroof et al., 2010) . To add the capacity of isolating interneuron progenitors, this line was modified with an additional BAC in which mCherry expression is driven by the Nkx2.1 gene ( Fig. 2A,B ; see Materials and Methods).
Of note, the same BAC has previously been used to drive Cre recombinase in Nkx2.1-expression domains of transgenic mice, although Cre-expression was weak within Nkx2.1-expressing cells of the dorsal-most proportion of the MGE .
In the telencephalon, Nkx2.1 is expressed in the proliferative zones of the MGE and preoptic area, and is downregulated in migratory cINs after cell cycle exit, but persists in striatal interneurons and in PV + projection neurons of the globus pallidus (Marin et al., 2000; Flandin et al., 2010) . Both the induction and the maintenance of Nkx2.1 expression in MGE progenitors are normally dependent on Shh signaling (Fuccillo et al., 2004; Xu et al., 2005) . In contrast, Lhx6 is stably expressed in essentially all MGE-derived GABAergic interneurons from the time of cell cycle exit into adulthood (Lavdas et al., 1999; Fogarty et al., 2007) . Fluorescence in situ hybridization (FISH) analysis revealed a single integration site of the Nkx2.1::mCherry BAC in chromosome 4 (supplementary material Fig. S1A ). Additionally, the line primarily used in this analysis, JQ27, formed morphologically typical ESC colonies when plated onto mouse embryonic fibroblasts (MEFs) and standard embryoid bodies (EBs) when floated on a non-adherent substrate (supplementary material Fig. S1B,C) . At DD12, all mCherry + cells differentiated from this line co-express Nkx2.1 (Fig. 2C) , although some Nkx2.1 + cells are not mCherry expressing. As expected, a subset of differentiating cells express both Lhx6::GFP and Nkx2.1:: mCherry (Fig. 2D) . Also as expected, DD12 FACS-isolated Nkx2.1::mCherry-expressing cells, replated onto matrigel in differentiation medium (Neurobasal/B27), strongly express Lhx6:: GFP within 24-36 h (supplementary material Movie 1). (G) Nkx2.1::mCherry (red) and Lhx6::GFP (green) immunofluorescence on JQ27 mESCs at DD12. Error bars indicate mean values from three independent experiments±s.d. DD, differentiation day; E, embryonic day. Scale bars: 300 μm in A; 150 μm in C,D; 400 μm in G.
Using the protocol described in Fig. 1B , we determined the time course of expression of Nkx2.1 protein along with Nkx2.1:: mCherry and Lhx6::GFP. EBs were dissociated and plated onto an adherent substrate as a low-density monolayer on DD3 (100,000 cells/ml). A few Nkx2.1::mCherry + cells appeared scattered throughout the culture on DD6 (0.7±0.2%); this percentage increased by DD8 (6.4±0.7%) and peaked at DD12 (16.5±3.9%; Fig. 2E ). Lhx6::GFP expression was barely detectable at DD6 (0.2±0.1%), nominally increased by DD8 (0.7±0.2%), then peaked at DD12 (19.7±2.0%), before decreasing as a percentage of all cells at DD15 (13.5±3.1%). A representative FACS plot at DD12 is shown, in which three distinct populations segregate from the autofluorescent background: mCherry single-positive, GFP single-positive and mCherry+GFP-double-positive cells (Fig. 2F ). Immunofluorescence analysis of mCherry and GFP confirms the FACS-based reporter induction data ( (Fig. 3B ,Ba). As expected for a reporter driven by promoter elements of Nkx2.1, which is downregulated in cINs shortly after cell cycle exit (Marin et al., 2000) , neither Nkx2.1 protein nor mCherry is detected in transplants of cells FACS-isolated for this reporter ( Although a detailed understanding of the molecular bases for cIN subgroup specification is not known, for the MGE-derived SST-or PV-expressing subgroups several factors influence their fate determination. First, whereas, within a given cortical layer, PVand SST-expressing interneurons have similar birthdates (Cavanagh and Parnavelas, 1988; Rymar and Sadikot, 2007) , the predominance of PV over SST subgroups in the later-born, superficial cortical layers corresponds to a larger percentage of all SST interneurons being generated earlier than all PV interneurons (Butt et al., 2005; Xu et al., 2010b) . Second, higher levels of signaling for the morphogen Shh in dorsal MGE appears to bias those Nkx2.1-expressing progenitors to generate SST-expressing interneurons (Xu et al., 2005 (Xu et al., , 2010a Wonders et al., 2008 ) (schematized in Fig. 4A ).
To determine whether Shh signaling influences interneuron fate in the mESC system, we first sought to direct mESCs towards either a dorsal or ventral MGE-like fate by providing higher or lower levels of Shh signaling during differentiation (Fig. 4A ,B-Bb). As shown above, cultures exposed to 50 nM Shh from DD5-12 produced many Nkx2.1-and Lhx6-expressing cells, but we were initially surprised to find that, in the absence of exogenous Shh (but after exposure to XAV), there was only a moderate reduction in numbers of these cells (Fig. 4B-F) . Addition of the Shh signaling antagonist cyclopamine to the no-exogenous Shh condition dramatically reduced both Nkx2.1 and Lhx6::GFP induction (Fig. 4Bb,Dc,F) . As Shh signaling is required for both the induction and the maintenance of Nkx2.1 expression (Fuccillo et al., 2004; Xu et al., 2005) , this result indicates that the no-exogenous Shh condition contains endogenous Shh signaling. We thus designate it as a 'lowShh' condition in contrast to the 'high Shh' signaling condition produced by addition of Shh. Importantly, Nkx2.1::mCherry cells exposed to the high Shh condition have increased co-localization with Nkx6.2 relative to the low Shh condition ( Fig. 4H ; quantified by RT-PCR in Fig. 4G ). As our previous studies have demonstrated that the higher levels of Shh signaling induce Nkx6.2 in the dorsal MGE relative to ventral MGE (Xu et al., 2005 (Xu et al., , 2010a , and, as the relative levels of Nkx2.1 and Nkx6.2 transcript are similar in high versus low Shh-exposed cultures as they are in dorsal versus ventral MGE cells (Fig. 4I,J) , Nkx2.1::mCherry + cells in our high and low Shh protocols have features of dorsal versus ventral MGE, respectively. Based on the temporal and spatial/Shh signaling influence on SST versus PV fate determination in vivo, we next sought to determine whether manipulations of these factors can enrich for SST-versus PVexpressing interneuronal fates. To confirm that differential exposure to Shh alone could influence interneuron fate determination, we compared transplants of Lhx6::GFP-expressing cells at DD14 that were exposed to either the high or the low Shh conditions (Fig. 5A-E) . As the high Shh condition enriches for Nkx6.2, which in vivo is enriched in the dorsal MGE in progenitors of SST-expressing interneurons (Fogarty et al., 2007; Sousa et al., 2009) , as well as in the preoptic area, where they give rise to Lhx6 − interneuron progeny (Gelman et al., 2009 ), we predicted that high Shh would enhance the generation of the SSTexpressing subgroup (Fig. 5C-Db) . Indeed, high Shh levels resulted in a strong bias for more Lhx6::GFP + cells to become SST-than PVexpressing ( Fig. 5E ; 55/82, 67.1±1.9% SST, versus 9/82, 11.1±3.9% PV; n=3 brains, P<0.001). In the low Shh condition, GFP + cells were more than twice as likely to differentiate into PV-expressing interneurons, whereas the percentage of cells differentiating into SST-expressing interneurons was greatly reduced ( Fig. 5E ; 18/79 cells, 25.9±6.8% GFP/PV, versus 30/79, 40±4.4% GFP/SST; n=3 brains, P<0.05). Scale bars: 50 μm. DD, differentiation day; PV, parvalbumin; SST, somatostatin.
Although these results support our previous evidence that Shh signaling promotes SST over PV fates (Xu et al., 2010a) , the yield of PV + interneurons remained relatively low even in the low Shh condition. To determine whether time in culture can also be used to manipulate fates, we employed two approaches. First, we collected cells at different times. As later collections of GFP + cells would contain a mix of cells born from around DD8 onwards, we also collected cells based on expression of mCherry. Although mCherry protein is likely to perdure transiently in post-mitotic cells after downregulation of Nkx2.1, at any time in culture the mCherry population that is fated to become Lhx6-GFP + interneurons, and thus be visible in our transplantation assay, will tend to be younger than the GFP + population. Our live imaging is consistent with this paradigm, as the Nkx2.1::Cherry signal decreases over a 36-h period, whereas Lhx6::GFP signal becomes stronger (supplementary material Movie 1). To compare effects of time in culture and maturational state (i.e. Nkx2.1::mCherry versus Lhx6:: GFP) on interneuron fates in our system, we compared transplants of GFP-versus mCherry-expressing cells from collections at DD12, 14 and 17 ( Fig. 5F-H To maximally enrich differentiations for PV-versus SST-fated cells, neonatal pups were transplanted with high-Shh protocol, Lhx6::GFP FACS-isolated cells on DD12 (Fig. 6A) , or with lowShh protocol, Nkx2.1::mCherry-expressing cells on DD17 (Fig. 6B) Fig. 6Ba -Bd,Ae). Both protocols yielded ∼25% Lhx6::GFP + cells expressing neither PV nor SST (Fig. 6Ae ,Be), consistent with our previous observations (Maroof et al., 2010; Petros et al., 2013) . These PV − and SST − cells generally expressed GABA, but did not co-label for markers of other interneuron subgroups, such as calretinin, calbindin, reelin or neuropeptide Y (Npy) (data not shown). .0% SST; n=4 independent differentiations, 11 brains total; P<0.001). Interprotocol differences in PV versus SST co-labeling with GFP are significant, P<0.001. DD, differentiation day; PV, parvalbumin; SST, somatostatin. Scale bars: 100 μm in Aa,Ba; 50 μm in Ac,Bc.
Transplanted JQ27-derived cINs have MGE-interneuron-like spiking characteristics
The fate-related data described herein strongly suggest that, as we found with the Lhx6-GFP parent line (J14; Maroof et al., 2010) , JQ27-derived cells can differentiate into neurons that exhibit features of MGE-derived cIN subgroups in vivo. To test this directly, we examined the biophysical properties and the functional incorporation of transplanted Nkx2.1:mCherry cells that had been differentiated as described for Fig. 4B . Whole-cell patch-clamp recordings were performed on GFP + cells in acutely prepared cortical slices between 60 and 70 DPT (Fig. 7) . We recorded a total of 14 GFP + cells across nine brains ( Table 1 ) and found that GFP + cells could be characterized into two physiologically distinct populations. Non-fast-spiking (NFS) patterns frequently correlate with SST expression, whereas cells exhibiting fast-spiking (FS) firing patterns are typical of the PV-expressing interneurons (Kawaguchi and Kubota, 1996) . As predicted, we observed both SST + NFS patterns (accommodating, average AP 1/2 width 0.84±0.09 ms, Fig. 7A -Ac) and PV + FS patterns (non-accommodating, average AP 1/2 width 0.48±0.03 ms, Fig. 7B-Bc) . Average resting membrane potentials (RMPs) were similar for both FS and NFS cells and typical of endogenous mature cINs (−70.7±5.8 mV and −66.3±5.1 mV, respectively).
DISCUSSION
This study aimed to accomplish three objectives: (1) to increase the efficiency of generating ventral telencephalic mESC-derived neurons; (2) to generate a dual-reporter mESC line that enables the isolation of MGE-like cIN progenitors (Nkx2.1 + ), as well as their cIN progeny (Lhx6 + ); and (3) to generate highly enriched populations of either PV-or SST-fated precursors by recapitulating developmental programs in vitro. Progress in each of these endeavors provides a robust system for the study of cIN fate determination, along with the ability to generate large numbers of selectively fated PV versus SST interneuron precursors for transplantation studies. These findings build upon previous reports that Wnt signaling inhibition with Dkk1 during the initial phase of stem cell differentiation potentiates expression of the telencephalic marker Foxg1 (Watanabe et al., 2005; Danjo et al., 2011) . We find that Wnt signaling inhibition by the small molecule XAV939 greatly increases the efficiency of generating ventral telencephalic patterning in mESCs, as we achieve a near 100% differentiation to Foxg1 + progenitors (Fig. 1 ). Dkk1 acts through binding to the Wnt coreceptor Lrp6 (Mao et al., 2001) . By contrast, XAV939 inhibits Wnt signaling by inhibiting tankyrase, resulting in increased cytosolic axin and enhanced degradation of β-catenin (Huang et al., 2009; Fancy et al., 2011) . In human ESC differentiation, XAV939 treatment also significantly increases Foxg1 induction relative to Dkk1 (Maroof et al., 2013) . This increase in induction efficiency for Foxg1 suggests that XAV939 is probably more stable or more potent in inhibiting Wnt signaling than recombinant Dkk1.
An additional benefit of XAV939 treatment is that it results in telencephalic differentiation that is heavily ventralized, with many cells expressing Nkx2.1, without the addition of Shh (Fig. 4) . However, consistent with previous reports on the requirement of Shh signaling for both the induction and the maintenance of Nkx2.1 (Fuccillo et al., 2004; Xu et al., 2005; Flandin et al., 2011) , cyclopamine nearly eliminates this Nkx2.1 expression (Fig. 4) . This situation allows us to consider differentiations not exposed to exogenous Shh to be a relatively low Shh condition, compared with those exposed to 50 ng/ml Shh. Importantly, the exogenous-Shh condition induces expression of Nkx6.2 in many Nkx2.1-expressing progenitors (Fig. 4) . Nkx6.2 is expressed in the dorsal MGE together with other genes associated with higher levels of Shh signaling, such as Gli1 and Hip1 (Wonders et al., 2008) . Nkx6.2 is also enriched in progenitors of SST-expressing interneurons (Fogarty et al., 2007; Sousa et al., 2009 ), which transplantation experiments have shown to be enriched in the dorsal MGE (Flames et al., 2007; Inan et al., 2012) . By using Wnt inhibition early in the differentiation, together with varying levels of Shh, we have thus created culture conditions that replicate aspects of intra-MGE patterning.
To determine whether the patterning-like effects of Shh on the ESC differentiations matches predicted effects on interneuron fates, we compared the effect of exogenous (for the current discussion 'high') Shh versus no exogenous ('low') Shh on the fates ES differentiations sorted for Lhx6::GFP at DD14. Indeed, the low Shh condition resulted in a significantly higher ratio of PV:SST fates than the high Shh condition (Fig. 5) . These results are consistent with Shh signaling playing an instructive role in the differential fate determination of SST versus PV interneurons (Xu et al., 2010a) . Of note, it has also been reported that removal of Shh from the MGE mantle reduces both SST and PV interneurons by similar proportions (Flandin et al., 2011) . However, as PV interneurons might preferentially originate from MGE subventricular zone (SVZ) divisions that would be closer to the MGE mantle source of Shh (Glickstein et al., 2007; Lodato et al., 2011) , the net effect of Shh loss in the MGE mantle on cIN composition is difficult to determine without knowing how Shh signaling itself is altered by this loss within the various populations of MGE progenitors.
Although Shh alteration alone significantly affected the interneuron fates of Lhx6::GFP + cells transplanted from differentiation of mESCs, the effect was partial. As birthdate has also been associated with differential fates of MGE progenitors, we compared the transplanted fates of collections from various times of differentiation, and also collected cells based on Nkx2.1::mCherry expression. As expected, transplantation of mCherry-expressing cells resulted in plentiful identification of Lhx6::GFP-expressing cells in transplanted neocortex, and none of these cells expressed mCherry or Nkx2.1 ( Fig. 3; supplementary material Fig. S6 ). In addition to the Shh effect noted above, there were significant effects of time and Nkx2.1::mCherry collection on interneuron fate (Fig. 5) . In sum, early (differentiation day 12) collection and transplantation of Lhx6-expressing cells from the high Shh condition resulted in a roughly 6:1 ratio of SST to PV interneurons, whereas late (day 17) collection of mCherry-expressing cells from low Shh condition resulted in a roughly 3:1 ratio of PV to SST interneurons (Fig. 6) .
Although cells collected based on Nkx2.1::mCherry expression at a given stage and condition give rise to relatively more PV interneurons than do those collected by their Lhx6::GFP expression, it is appropriate to note that maturational stage or birthdate is not likely to be the only determinant of this difference. The Nkx2.1-Cre mouse generated with the same BAC used in this paper had relatively weak expression of Cre in the dorsal-most MGE, and fate mapping of this mouse labeled a modestly higher proportion of neocortical PV interneurons (roughly 80%) than of SST interneurons (roughly 70%) . It is therefore likely that some of the enrichment for PV fates seen with Nkx2.1::mCherry collections is due to a partial bias for this transgene to express in progenitors of PV versus SST interneurons.
In summary, we demonstrate the ability to isolate enriched populations of differentially fated mESC-derived PV + or SST + cIN subgroups at the time of fate conferral. Furthermore, this is the first report of a dual-BAC reporter ESC system employed to isolate differentially fated forebrain subgroups within a common neuronal class, a valuable approach applicable to other lineages of interest. In addition to the implications of this work for identification of genes differentially expressed in the post-mitotic precursors of two major cIN subclasses, it is now possible to use mESCs to explore preclinical cell-based therapies for disorders thought to involve specific deficits in these neurons, including epilepsy and schizophrenia.
MATERIALS AND METHODS
Generation of the JQ27 mES-Lhx6::GFP/Nkx2.1::mCherry line
The previously generated J14 mES-Lhx6::GFP line (Maroof et al., 2010) was modified with an Nkx2.1::mCherry-containing BAC, using the same BAC (RPCI-23-3H18) used to obtain expression of Cre in Nkx2.1-expressing cells in transgenic mice . This BAC was modified such that mCherry replaces most of exon 2 of Nkx2.1 in frame, and a blastocidin resistance cassette was inserted into the BAC backbone for subsequent mammalian selection (Tomishima et al., 2007) . This BAC was then electroporated into the mESC line (J14) to generate the Lhx6::GFP/ Nkx2.1::mCherry line. Karyotype and FISH analysis revealed a single integration site on chromosome 13 of Lhx6::GFP and a single integration site on chromosome 4 of Nkx2.1::mCherry (supplementary material Fig. S1 ).
mESC culture
Mouse ESCs were grown on mouse embryonic fibroblasts (MEF CF-1 MITC7M, GSC-6101M, Global Stem) in standard mESC medium {knockout DMEM [Invitrogen] , 15% FBS [Invitrogen-Thermo Fisher Scientific], supplemented with L-glutamine, primocin, MEM nonessential amino acids, β-mercaptoethanol and LIF [1.4 µl/ml (10 7 U/ml)] ESG1107, Millipore}. For differentiation, mESCs were treated with 0.05% trypsin and suspended at 70,000 cells/ml (Maroof et al., 2010; Watanabe et al., 2005) . Floating embryoid bodies (EBs) were grown in a 1:1 mixture of KSR (10828-028, Invitrogen) and N2 media (DMEM:F12, 11330, Invitrogen; N2 07156, Stemgent) supplemented with LDN-193189 (250 nM, 04-0074, Stemgent) and XAV939 (10 μM, 04-0046, Stemgent). On DD3, EBs were dissociated using accutase (A1110501, Invitrogen) and plated onto poly-Llysine (P6282, Sigma)-and laminin (L2020, Sigma)-coated plates at 100,000 cells/ml in N2:KSR medium. On DD5, XAV and LDN treatment ceased, and medium was supplemented with FGF-2 (10 ng/ml, DD5-9, 233-FB, R&D Systems), IGF1 (20 ng/ml, day 5-9, 291-G1-200/CF, R&D Systems), with or without Shh (50 ng/ml, Shh-N-C25II, R&D Systems; DD5-12). Medium was changed at DD0, DD3 and every other day until FACS sorting or IHC analysis. Y-27632 (10 nm, Tocris) was added prior to EB dissociation at DD3 and again prior to terminal dissociation and during FACS. Cultures were fixed and analyzed by immunofluorescence or subjected to FACS.
Cell sorting
Cells were treated with accutase (Invitrogen) for 30 min, followed by gentle trituration to dissociate to single cells. The cells were centrifuged at 1000 rpm (250 g) for 5 min, resuspended in DMEM:F12 (11039-021, Invitrogen) with 20% HyClone FBS (Atlanta Biologicals) and Y-27632 (10 nm, 1254, Tocris), then passed twice through a 40-μm filter. The cell suspension was kept on ice until FACS (Aria II, BD Biosciences) and analyzed using FACS Diva software (version 6.1.3).
Gene expression profiling
Total RNA was extracted from day 12 mESC differentiations or E12.5 MGE using an RNeasy kit (Qiagen). For each sample, 1 µg of total RNA was treated for DNA contamination and reverse-transcribed using the Quantitect RT kit (Qiagen). Amplified material was detected using TaqMan probes detecting either Nkx2.1 (Mm00447558_m1) or Nkx6.2 (Mm00807812_g1) and using a PCR kit (Applied Biosystems) on a Mastercycler RealPlex2 (Eppendorf ). All results were normalized to a Gapdh control gene, with a cut-off at 45 cycles, and Δ Ct values were calculated by comparison to results from RNA samples isolated from undifferentiated ESCs. There were two replicates of three independent samples at each data point.
Neonatal cortical transplantation
Transplantation into the somatosensory neocortex of cooling-anesthetized neonatal pups was conducted as described previously (Maroof et al., 2010; Wonders et al., 2008) . Between 20,000 and 40,000 cells were injected into the cortical plate at the following coordinates from bregma (2.0 mm anterior, 2.5 mm lateral, 1.0 mm deep), targeting cortical layers 3-6 of CD1 pups at P0-1. Animal care was in accordance with institutional guidelines at the Weill Cornell Medical College and The Children's Hospital of Philadelphia.
In vitro immunohistochemistry
Cells were fixed in 4% paraformaldehyde, blocked in BSA/PBST, in some cases pretreated with 1 mM ETDA/PBS (65°C, 5 min), then immunolabeled with antisera: rabbit anti-Lhx6 (1:1000, a gift from V. Pachnis, Division of Molecular Neurobiology, MRC National Institute for Medical Research, London, UK), rabbit anti-Foxg1 (Neuracell; 1:1000), chicken anti-GFP (Abcam, ab13970; 1:1000), mouse anti-Nkx2.1 (Abcam, ab76013; 1:500), rat anti-RFP antibody (Chromtek, 5F8; 1:400), mouse anti-Tuj1 (Promega, G712A; 1:1000), rabbit anti-Nkx6.2 (1:500, a gift from M. Sander, UCSD School of Medicine Department of Pediatrics, Department of Cellular & Molecular Medicine) and nuclear staining with DAPI (Invitrogen, D3971). Secondary antibodies were conjugated to Alexa fluorophores (488, 568 or 680, Invitrogen) or Cy5 (Jackson ImmunoResearch).
In vivo fate quantification
Fixed brains were sectioned in the coronal plane at 50 μm on a vibrating microtome (Leica). Sections including somatosensory cortex were labeled with chicken anti-GFP (Abcam, ab13970; 1:1000) immunofluorescence, rabbit anti-PV (Swant, PV-25; 1:2000) , rat anti-SST (Millipore, 14224; 1:2000) , rabbit anti-GABA (Sigma-Aldrich, A2052; 1:1000), rabbit antiSox6 (Abcam, ab30455; 1:2000) , rabbit anti-Npy (Immunostar, 22940; 1:300) or goat anti-choline acetyltransferase (Millipore, AB144P; 1:500) and nuclear staining with DAPI. Secondary antibodies were conjugated to Alexa fluorophores (Invitrogen) or Cy5 (Jackson ImmunoResearch). Generally, 12-15 sections were evaluated per marker. Transplanted animals were excluded if there were fewer than 25 total GFP + cells present, and only GFP + cells engrafted in cortical layers 2-6 were included in fate analysis. Each condition in which both timing and exposure to exogenous Shh were varied was repeated on at least three separate occasions, with a minimum of two transplanted mice per condition. Therefore, a statistical n represents counts from multiple transplants of one differentiation experiment. Statistical significance was determined using a two-tailed Student's t-test. A one-way ANOVA for SST:PV ratios of co-labeling with GFP over time at collection and mode of collection (mCherry or GFP) was calculated using StatPlusPro (AnalystSoft). The false discovery rate for both data sets was <0.0001. For each time point (DD12, 14 or 17) PV and SST fate ratios were calculated from at least three brains.
Slice preparation
Brain slices were prepared from mice (60-70 DPT) as described (Goldberg et al., 2011) . Slices (275 μm thick) were cut on a microtome (Leica VT1200S) and incubated in a holding chamber at 32°C for 30 min, then at room temperature prior to recording. Artificial cerebrospinal fluid (ACSF) used for recording contained: 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 10 mM glucose, 2 mM CaCl 2 and 1 mM MgSO 4 .
Electrophysiological recordings
GFP-expressing neurons were visualized using a 40× water-immersion objective on an Olympus BX-51 upright microscope. Current clamp recordings were performed using the whole-cell patch-clamp technique. Access resistance (R s ) was <25 MΩ upon break-in; data obtained from a given cell were rejected if R s changed by >20% during the experiment. Internal solution contained: 130 mM potassium gluconate; 6.3 mM potassium chloride; 0.5 mM EGTA; 1.0 mM MgCl 2 ; 10 mM HEPES; 4 mM Mg-ATP; 0.3 mM Na-GTP. Osmolarity was adjusted to 285-290 mOsm using 30% sucrose. Voltage was recorded using a MultiClamp 700B amplifier (Molecular Devices), low-pass-filtered at 10 kHz, digitized at 16-bit resolution (Digidata 1440) and sampled at 20 kHz. Data were acquired and analyzed using pCLAMP 10 software and Clampfit (Axon Instruments). RMP (V m ) was defined as the mean membrane potential during a 10-s baseline current clamp recording; membrane resistance (R m ) was calculated as the slope of the linear fit of the voltage/current relation near V m ; action potential half-width (AP 1/2-width) was calculated as the width of the AP at half maximal amplitude from AP threshold to peak of the AP; spike frequency adaptation was calculated as the ratio of the first to the tenth (ISI 1 /ISI 10 ) or last (ISI 1 /ISI n ) peak-to-peak interspike interval. For post-recording immunocytochemistry, 0.5% neurobiotin (Vector Labs) was included in the internal solution. Slices were fixed in 4% PFA for 4 h and subjected to immunofluorescence analysis for neurobiotin (streptavidin-conjugated 546, Jackson), and either PV (mouse anti-PV, Millipore; donkey anti-mouse Cy5) for FS cells (6 of 14 recorded) or somatostatin (rat anti-SST, Millipore; donkey anti-rat Cy5, Jackson) for the non-FS cells (8 of 14).
